Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Potential symbols : Azn save search
AstraZeneca to Acquire Icosavax, Including Potential First-in-class RSV and hMPV Combination Vaccine With Positive Phase II Data
Published: 2023-12-12 (Crawled : 15:30) - biospace.com/
AZNCF | $138.24 800
|
Health Technology
|
| O: 5.03%
H: 0.0%
C: -3.82%
ICVX | $15.31 -0.65% 9.3M
|
|
| O: 53.48%
H: 1.02%
C: 0.26%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: 1.54%
H: 0.06%
C: -0.78%
vaccine astrazeneca positive acquire rsv potential
Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications
Published: 2023-05-03 (Crawled : 11:00) - globenewswire.com
SEOVF | $0.3295 29K
|
Health Technology
|
| O: 16.67%
H: 2.81%
C: -4.73%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: 0.75%
H: 0.98%
C: 0.46%
cell research collaboration potential
Extensive Stage Small Cell Lung Cancer Global Market Report 2022: Need of Potential Treatments to Improve Quality of Life Drives Sector
Published: 2022-12-22 (Crawled : 17:00) - prnewswire.com
AZNCF | $138.24 800
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
JAZZ | $109.03 -0.22% 66K
|
Health Technology
|
| O: -0.06%
H: 1.27%
C: 0.93%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: -0.04%
H: 0.32%
C: 0.31%
lung global report life potential cancer market
Travel Vaccine Global Market Report 2022: Growth Potential in Emerging Economies Presents Lucrative Opportunities
Published: 2022-12-06 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.74%
H: 8.46%
C: 8.46%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.64%
H: 0.04%
C: -2.12%
ABT | News | $107.24 1.87% 2M
|
Health Technology
|
| O: -0.4%
H: 0.4%
C: -1.08%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: -0.48%
H: 1.59%
C: 0.69%
global report vaccine travel potential growth market
Vaccines Market Potential to Grow by USD 28.28 billion | Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd. Emerge as Dominant Players | Technavio
Published: 2022-05-02 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
AZNCF | $138.24 800
|
Health Technology
|
| O: -1.7%
H: 0.0%
C: -0.06%
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -1.05%
H: 0.2%
C: -0.27%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: -0.92%
H: 0.29%
C: -0.95%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -2.05%
H: 0.0%
C: 0.0%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
pharma biotech potential market
Investor Alert: Kaplan Fox Investigates Potential Securities Fraud At AstraZeneca PLC
Published: 2021-01-30 (Crawled : 03:10) - prnewswire.com
AZN | $68.545 0.27% 1.2M
|
Health Technology
| Email alert
Add to watchlist
potential
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Invites AstraZeneca (AZN) Investors to Contact Firm, Securities Fraud Case Related to Potential COVID-19 Treatment Filed
Published: 2021-01-28 (Crawled : 09:07) - prnewswire.com
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: 0.04%
H: 1.57%
C: -0.15%
covid treatment trial potential
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
NVFY | $3.45 63.51% 20M
|
Consumer Durables
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.